Bharat Biotech signs agreement with Ocugen to commercialize Covaxin in US
According to the agreement, Ocugen will have the commercial rights to administer vaccines to candidates in the United States and will be responsible to conduct clinical trials and acquire emergency use authorization from the United States Food and Drug Administration. ...